Many previous studies have demonstrated the key role of NLRP3 inflammasome in the progress of all kinds of liver disease models including LPS/D-Gal-induced acute liver injury (Kim and Lee, 2013; Liu et al., 2018; Jimenez Calvente et al., 2020). Here, NLRP3 is linked to liver disorder.